NPI: 1376516039 · LITTLE ROCK, AR 72204 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 30,101 | $305K |
| 2019 | 36,283 | $309K |
| 2020 | 45,452 | $259K |
| 2021 | 41,528 | $155K |
| 2022 | 23,203 | $173K |
| 2023 | 9,226 | $130K |
| 2024 | 5,603 | $133K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 75,959 | 3,490 | $541K |
| 83970 | 3,824 | 2,368 | $262K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 49,969 | 2,366 | $192K |
| 82728 | 2,721 | 1,721 | $119K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 28,916 | 1,686 | $65K |
| 83550 | 2,439 | 1,541 | $55K | |
| 83540 | 2,750 | 1,730 | $51K | |
| A4657 | Syringe, with or without needle, each | 3,448 | 2,200 | $47K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 930 | 386 | $45K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 423 | 276 | $37K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,514 | 604 | $17K |
| 82108 | 155 | 98 | $17K | |
| 85041 | 3,600 | 2,164 | $6K | |
| 85048 | 3,597 | 2,162 | $4K | |
| J1756 | Injection, iron sucrose, 1 mg | 8,643 | 1,710 | $2K |
| G0008 | Administration of influenza virus vaccine | 130 | 86 | $542.09 |
| 82570 | 27 | 12 | $511.30 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 2,189 | 551 | $467.63 |
| 90674 | 98 | 67 | $0.00 | |
| 86706 | 23 | 21 | $0.00 | |
| 85045 | 41 | 27 | $0.00 |